GrowthCap announced its Top 25 Healthcare Investors of 2022. Over 800 investors were considered at the start of this year’s nomination process, the organization said.
Managing directors at Bain Capital rnaked #1 on the list.
To determine the awardees, they focused on feedback received from portfolio company CEOs, firm colleagues and peers in the industry as well as proprietary research. The 2022 awardees represent a diverse set of individuals with backgrounds in medicine, science, and technology in addition to finance and investing. Across growth equity and growth buyouts in addition to emerging growth and venture, what these investors all have in common is demonstrated exceptional performance in the areas of investment selection, value creation, and ESG engagement.
This year’s awardees were nominated by their firms, portfolio companies, healthcare industry colleagues, and/or peers at other investment firms. More specifically, awardee selections and rankings were based on deal experience and track record, strategic and operational capabilities provided to portfolio companies, unique and differentiated attributes, as well as contributions to ESG, DEI, charitable work, and overall industry advancement.
